Building An AM Quality Data Backbone That Makes AI Credible 
Visionstate Announces $750,000 financing to Support International Expansion and Strategic Growth 
Local AI Registry Launches First Public Registry of AI Business Recommendations 
Agereh Technologies to Attend 2026 ACI-NA Annual Conference & Exhibition in Philadelphia 
FlameProxies Launches Residential Proxy Network Across 180 Countries Without Contract Commitments Valneva Announces Positive Homologous Booster Data for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
Initial results show excellent immune response after third dose of VLA2001 administered 7 to 8…
Issue of Shares to Employee Benefit Trust
This announcement contains inside information for the purposes of Article 7 of the Market Abuse…
Novartis initiates new USD 15 billion share buyback highlighting confidence in growth and pipeline
Ad hoc announcement pursuant to Art. 53 LR Share buyback of up to USD 15bn…
On substantial participation (4)
On December 15th, 2021 JSC Olainfarm has received announcement on substantial participation from AS AB…
FDA’s OTAT in Agreement With 12-Month Reduction in Pain as Primary Endpoint for Chronic Low Back Pain Program
NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
Immix Biopharma, Inc. Announces Pricing of Initial Public Offering
LOS ANGELES, Dec. 15, 2021 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio” or the…
Antares Pharma Announces Divestiture of Otrexup®
EWING, N.J., Dec. 15, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”),…
Assertio Holdings, Inc. Announces the Acquisition of Otrexup® (methotrexate) a Drug Device Combination from Antares Pharma, Inc.
Trailing 12 Month Reported Revenues of Otrexup Were $15.5 Million Assertio will Pay Antares $18.0…
Universe Pharmaceuticals INC Appoints Mr. Baochang Liu as Chief Operating Officer
Ji’an, Jiangxi, China, Dec. 15, 2021 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (the “Company”) (Nasdaq:…
IBEX Reports Results for the First Quarter Ended October 31, 2021
MONTRÉAL, Dec. 15, 2021 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX…
Lyell Immunopharma Announces cGMP Qualification of LyFE™ Manufacturing Center in Advance of Initiating Clinical Programs
Lyell’s cGMP-compliant manufacturing facility, is designed to produce cell products at scale for upcoming clinical…
Enzo Biochem Reports First Quarter 2022 Financial Results and Provides Business Update
1Q FY 2022 revenues of $26.5 million vs. $24.8 million in 4Q FY 2021, representing…
Verrica Pharmaceuticals Announces Acceptance by FDA of NDA Resubmission for VP-102 for the Treatment of Molluscum Contagiosum
WEST CHESTER, Pa., Dec. 15, 2021 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA),…
Ensysce Biosciences Announces First Patients Enrolled in Phase 1 Study of PF614-MPAR™, its unique technology platform to provide opioid overdose protection
SAN DIEGO, Dec. 15, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”)…
Elucida Oncology to Present Preclinical Data on ELU001 at the Antibody Engineering & Therapeutic Conference
MONMOUTH JUNCTION, N.J., Dec. 15, 2021 (GLOBE NEWSWIRE) — Elucida Oncology, a clinical-stage biotechnology company…
Tricida to Present at the 40th Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) — Tricida, Inc. (Nasdaq: TCDA) today announced…
UPDATE — PAOG Recommends Its RelaxRX Full Spectrum CBD To Ease Stress Before Fed Decision
Sandusky, OH, Dec. 15, 2021 (GLOBE NEWSWIRE) — PAO Group, Inc. (OTC Pink: PAOG) today…
Akoya Biosciences Unveils Comprehensive Roadmap of Innovations at Inaugural Spatial Day Event
Imaged on PhenoCycler-Fusion Zoom In A zoomed in section shows germinal centers with a concentration…
Avenue Therapeutics Announces Closing of Public Offering of Common Stock
NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (or the “Company”) (NASDAQ:…
Issuance of 2nd tranche of €500,000 of notes convertibles into new shares
Issuance of 2nd tranche of €500,000 of notes convertibles into new shares DEINOVE strengthens its…